Report Detail
European Markets for Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products
In Europe- which, for the purposes of this report, consists of the countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.)- the roles of electrocardiography and in vitro diagnostic (IVD) near-patient testing to diagnose and monitor patients with cardiovascular disease (CVD) will continue to advance for the foreseeable future. The economic pressures associated with healthcare delivery and the need for early and accurate diagnosis of cardiovascular events are factors that will fuel demand by healthcare providers and patients for noninvasive and relatively inexpensive electrocardiography and IVD near-patient testing protocols. Performance of these types of tests also will be positively influenced by demographic factors such as growth in the number of people living in Europe, the increasing proportion of national populations suffering from diabetes and obesity,and the aging of the populations in many of the countries in the region along with the subsequent rise in the prevalence of age-related cardiovascular conditions that require management.
The combined European market for electrocardiography products and CVD-related IVD near-patient testing products (for cardiac marker, cholesterol/lipid level, and coagulation status assessment) was valued at approximately $556.4 million in 2008; it is expected that during the forecast period covered by this report, the value of this market will expand at a compound annual rate of 6.7%, with sales reaching an estimated $770.5 million in the year 2013. Although the forecasts for the market segments presented in this report are conservative, they may prove overstated should the current worldwide economic downturn continue beyond the year 2010.
In 2008, among France, Germany, Italy, Spain, and the U.K., the largest country market for electrocardiography and CVD-related IVD near-patient testing productswas Germany, with sales of approximately $213.7 million or 38.4% of the total market value. The German market was followed by France with $191.0 million insales (34.3% of the total market), the U.K. with $68.7 million (12.4%), Italy with$47.4 million (8.5%), and Spain with $35.6 million (6.4%). In the year 2013, the largest country market for electrocardiography and CVD-related IVD near-patient testing products will be Germany with sales of approximately $298.1 million, followed by France with $264.2 million in sales, the U.K. with $94.5 million, Italy with $65.1 million, and Spain with $48.6 million.